脑部放疗,上午比下午敏感许多!, g4 J3 n/ \6 B. q
/ h U9 k# F- }5 Q6 J% M7 ^
6 E/ a) {. X: U* ?8 J( ?; t
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9." c3 i7 x/ \4 N2 w- h$ X
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
. v7 [& j1 o/ S R: h( d( CRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.9 J# c' }/ M9 H
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
" a" R) h+ J9 {/ {3 P/ [; L* Z) `) s
8 V$ q" f$ \( x9 L1 i) IAbstract- E+ b$ T6 e' d5 }! \" E
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.2 _: Z, G4 ^3 l+ L8 ]
8 @ d4 ^8 E) X+ G- g& {
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.: h9 Z2 i; u6 t% V m7 j
! a$ l+ w, k- G/ l2 ~& T: ^. X$ L) uRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
4 O4 L7 V9 D$ D3 k- c/ @4 ~* H2 F6 S5 Q. |9 L, H* u. h1 \8 B. U
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
( X* |. g9 Y% G6 w+ p' Q9 ?: w. P2 } b3 v4 Q3 I$ P
|